Interactions with and activation of immune cells by CD41a+ extracellular vesicles

被引:1
作者
Tamagne, Marie [1 ,2 ]
Khelfa, Mehdi [1 ,2 ]
Many, Souganya [3 ]
Neyrinck-Leglantier, Deborah [1 ,2 ]
Delorme, Adele Silane [1 ,2 ]
Pinheiro, Marion Klea [1 ,2 ]
Andrieu, Muriel [3 ]
Cleophax, Sabine [2 ]
Pirenne, France [1 ,2 ]
Vingert, Benoit [1 ,2 ]
机构
[1] Univ Paris Est Creteil, INSERM, IMRB, Creteil, France
[2] Etab Francais Sang, Ivry, France
[3] Univ Paris Cite, CNRS, Inst Cochin, INSERM U1016,UMR8104, Paris, France
来源
FRONTIERS IN IMMUNOLOGY | 2025年 / 16卷
关键词
extracellular vesicles (EVs); immune activation; platelet transfusion; immunomodulation; multi-omic analyses; TRANSFUSION-RELATED IMMUNOMODULATION; PLATELET MICROPARTICLES; CD40; LIGAND; T-CELLS; ANTIGEN; MICROVESICLES; NEUTROPHILS; COMPONENTS; RECEPTOR;
D O I
10.3389/fimmu.2025.1509078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction The immunological profiles of CD4+ T lymphocytes (TLs) from patients with hematological malignancies differ between patients who have and have not received transfusions. There may be several reasons for these differences, including the presence of extracellular vesicles (EVs) derived from plasma membrane budding and present in the platelet concentrates. Indeed, EVs can modulate the immune system through interactions with many immune cells, but the underlying mechanisms remain incompletely understood.Methods We therefore investigated how interactions with CD41a+ EVs cause immune cells to change phenotype and function. CD41a+ EVs were cultured with TLs, B lymphocytes, and monocytes. Given the potential involvement of monocytes in leukemia progression, we performed a new original multi-omics study to confirm the protein changes and gene activation observed following interaction with CD41a+ EVsResults The CD41a+ EVs had immunomodulatory effects on all these cell types but this effect depended on the numbers of EVs. CD4+ TLs required large numbers of CD41a+ EVs for activation, whereas monocytes were the most sensitive. With the new multi-omics technique, we confirmed the direct effects of CD41a+ EVs on protein phenotype and gene activation.Conclusion Transfusion EVs should be considered during the immunological follow-up of patients after transfusion to detect immunological effects on malignant hemopathies, and during the development of new immunotherapies.
引用
收藏
页数:12
相关论文
共 74 条
  • [1] Blandin L., Douge A., Fayard A., Bay J.O., Berlie G., Pereira B., Et al., Platelet transfusion refractoriness and anti-HLA immunization, Transfusion, 61, (2021)
  • [2] Hod E., Schwartz J., Platelet transfusion refractoriness, Br J Haematol, 142, (2008)
  • [3] Prodger C.F., Rampotas A., Estcourt L.J., Stanworth S.J., Murphy M.F., Platelet transfusion: Alloimmunization and refractoriness, Semin Hematol, 57, (2020)
  • [4] Doughty H.A., Murphy M.F., Metcalfe P., Rohatiner A.Z., Lister T.A., Waters A.H., Relative importance of immune and non-immune causes of platelet refrac-toriness, Vox Sang, 66, (1994)
  • [5] Dutcher J.P., Schiffer C.A., Aisner J., Wiernik P.H., Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized, Blood, 58, (1981)
  • [6] Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions, N Engl J Med, 337, (1997)
  • [7] Youssef L.A., Spitalnik S.L., Transfusion-related immunomodulation: a reappraisal, Curr Opin Hematol, 24, (2017)
  • [8] Remy K.E., Hall M.W., Cholette J., Juffermans N.P., Nicol K., Doctor A., Et al., Mechanisms of red blood cell transfusion-related immunomodulation, Transfusion, 58, (2018)
  • [9] Goubran H., Sheridan D., Radosevic J., Burnouf T., Seghatchian J., Transfusion-related immunomodulation and cancer, Transfus Apher Sci, 56, (2017)
  • [10] Gilson C.R., Zimring J.C., Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model, Transfusion, 52, (2012)